Randomised consent designs in cancer clinical trials

D. G. Altman*, J. Whitehead, M. K.B. Parmar, S. P. Stenning, P. M. Fayers, D. Machin

*Corresponding author for this work

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

In 1977, Zelen proposed a new design for clinical trials with the aim of increasing recruitment by avoiding some of the problems associated with obtaining informed consent. These 'randomised consent' designs have proved controversial, and have not often been used. This paper explains the statistical aspects of single and double randomised consent designs and reviews some of the ethical issues. All identified published cancer treatment trials using a randomised consent design are considered in some detail. Reasons for and against the use of these designs are summarised.

Original languageEnglish
Pages (from-to)1934-1944
Number of pages11
JournalEuropean Journal of Cancer
Volume31
Issue number12
DOIs
Publication statusPublished - Nov 1995

Fingerprint

Informed Consent
Ethics
Clinical Trials
Neoplasms

Keywords

  • cancer
  • clinical trials
  • ethics
  • randomised consent design
  • statistics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Altman, D. G., Whitehead, J., Parmar, M. K. B., Stenning, S. P., Fayers, P. M., & Machin, D. (1995). Randomised consent designs in cancer clinical trials. European Journal of Cancer, 31(12), 1934-1944. https://doi.org/10.1016/0959-8049(95)00470-X

Randomised consent designs in cancer clinical trials. / Altman, D. G.; Whitehead, J.; Parmar, M. K.B.; Stenning, S. P.; Fayers, P. M.; Machin, D.

In: European Journal of Cancer, Vol. 31, No. 12, 11.1995, p. 1934-1944.

Research output: Contribution to journalReview article

Altman, DG, Whitehead, J, Parmar, MKB, Stenning, SP, Fayers, PM & Machin, D 1995, 'Randomised consent designs in cancer clinical trials', European Journal of Cancer, vol. 31, no. 12, pp. 1934-1944. https://doi.org/10.1016/0959-8049(95)00470-X
Altman DG, Whitehead J, Parmar MKB, Stenning SP, Fayers PM, Machin D. Randomised consent designs in cancer clinical trials. European Journal of Cancer. 1995 Nov;31(12):1934-1944. https://doi.org/10.1016/0959-8049(95)00470-X
Altman, D. G. ; Whitehead, J. ; Parmar, M. K.B. ; Stenning, S. P. ; Fayers, P. M. ; Machin, D. / Randomised consent designs in cancer clinical trials. In: European Journal of Cancer. 1995 ; Vol. 31, No. 12. pp. 1934-1944.
@article{e59a8b30d7b14138ab83e5498abf7730,
title = "Randomised consent designs in cancer clinical trials",
abstract = "In 1977, Zelen proposed a new design for clinical trials with the aim of increasing recruitment by avoiding some of the problems associated with obtaining informed consent. These 'randomised consent' designs have proved controversial, and have not often been used. This paper explains the statistical aspects of single and double randomised consent designs and reviews some of the ethical issues. All identified published cancer treatment trials using a randomised consent design are considered in some detail. Reasons for and against the use of these designs are summarised.",
keywords = "cancer, clinical trials, ethics, randomised consent design, statistics",
author = "Altman, {D. G.} and J. Whitehead and Parmar, {M. K.B.} and Stenning, {S. P.} and Fayers, {P. M.} and D. Machin",
year = "1995",
month = "11",
doi = "10.1016/0959-8049(95)00470-X",
language = "English",
volume = "31",
pages = "1934--1944",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER APPL SCI PUBL LTD",
number = "12",

}

TY - JOUR

T1 - Randomised consent designs in cancer clinical trials

AU - Altman, D. G.

AU - Whitehead, J.

AU - Parmar, M. K.B.

AU - Stenning, S. P.

AU - Fayers, P. M.

AU - Machin, D.

PY - 1995/11

Y1 - 1995/11

N2 - In 1977, Zelen proposed a new design for clinical trials with the aim of increasing recruitment by avoiding some of the problems associated with obtaining informed consent. These 'randomised consent' designs have proved controversial, and have not often been used. This paper explains the statistical aspects of single and double randomised consent designs and reviews some of the ethical issues. All identified published cancer treatment trials using a randomised consent design are considered in some detail. Reasons for and against the use of these designs are summarised.

AB - In 1977, Zelen proposed a new design for clinical trials with the aim of increasing recruitment by avoiding some of the problems associated with obtaining informed consent. These 'randomised consent' designs have proved controversial, and have not often been used. This paper explains the statistical aspects of single and double randomised consent designs and reviews some of the ethical issues. All identified published cancer treatment trials using a randomised consent design are considered in some detail. Reasons for and against the use of these designs are summarised.

KW - cancer

KW - clinical trials

KW - ethics

KW - randomised consent design

KW - statistics

UR - http://www.scopus.com/inward/record.url?scp=0029564657&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(95)00470-X

DO - 10.1016/0959-8049(95)00470-X

M3 - Review article

C2 - 8562145

AN - SCOPUS:0029564657

VL - 31

SP - 1934

EP - 1944

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 12

ER -